Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 52

Results For "2022"

1420 News Found

Aptar Pharma launches highly recyclable nasal spray pump
News | January 31, 2023

Aptar Pharma launches highly recyclable nasal spray pump

APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors


Glenmark Life Sciences posts Q3 FY23 PAT at Rs. 104.99 Cr
News | January 29, 2023

Glenmark Life Sciences posts Q3 FY23 PAT at Rs. 104.99 Cr

The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022


Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr
News | January 29, 2023

Vimta Labs reports Q3 FY23 consolidated PAT at Rs. 10.24 Cr

The company has reported total income of Rs. 78.50 crores during the period ended December 31, 2022


Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in US
News | January 28, 2023

Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in US

The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA


Bliss GVS Pharma posts Q3 FY23 consolidated PAT at Rs. 27.94 Cr
News | January 28, 2023

Bliss GVS Pharma posts Q3 FY23 consolidated PAT at Rs. 27.94 Cr

The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022


Dr. Reddys Laboratories Q3 FY2023 consolidated PAT up to Rs. 1243.9 Cr
News | January 27, 2023

Dr. Reddys Laboratories Q3 FY2023 consolidated PAT up to Rs. 1243.9 Cr

The company has reported total income of Rs. 6848.5 crores during the period ended December 31, 2022


Torrent Pharmaceuticals posts Q3FY23 consolidated PAT at Rs. 283 Cr
News | January 27, 2023

Torrent Pharmaceuticals posts Q3FY23 consolidated PAT at Rs. 283 Cr

The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022


Pharma companies developing vaccines with efficacy against Omicron variants will gain competitive advantage in China, says GlobalData
News | January 27, 2023

Pharma companies developing vaccines with efficacy against Omicron variants will gain competitive advantage in China, says GlobalData

The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.


Granules Pharmaceuticals receives ANDA approval for amphetamine mixed salts ER capsules
Drug Approval | January 25, 2023

Granules Pharmaceuticals receives ANDA approval for amphetamine mixed salts ER capsules

Granules now have a total of 53 ANDA approvals from USFDA


Syngene Q3FY23 revenue reaches Rs. 803 Cr; PAT reaches Rs. 110 Cr
News | January 24, 2023

Syngene Q3FY23 revenue reaches Rs. 803 Cr; PAT reaches Rs. 110 Cr

The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid